Scripps Expert Discusses New Drug to Treat Type 2 Diabetes

Athena Philis-Tsimikas, MD, featured in 10 News report

Dr. Athena Philis-Tsimikas, Scripps Whittier Diabetes Institute

Athena Philis-Tsimikas, MD, featured in 10 News report

Athena Philis-Tsimikas, MD, corporate vice president of Scripps Whittier Diabetes Institute, recently discussed with 10 News a promising new diabetes drug that an FDA panel is recommending for approval. Scripps is one of the clinical trial sites for the oral version of this new drug known as semaglutide.


View the coverage on 10 News: Diabetes Drug Breakthrough.

Media Contact

Leonel Sanchez
858-678-6508
Sanchez.Leonel@scrippshealth.org
Follow me: @1LeonelSanchez